Hospital Hietzing   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Vienna Austria (1907)

Organization Overview

First Clinical Trial
2006
NCT00368264
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Hietzing Hospital Vienna, Austria | Hospital Hietzing

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronavirus Infections (Phase 3)

Edema (Phase 4)

Lupus Erythematosus, Systemic (Phase 3)

Lupus Nephritis (Phase 3)

Macular Degeneration (Phase 3)

Macular Edema (Phase 4)

Nephritis (Phase 3)

Papilledema (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 12